44 226 (Stay awake tabs Caffeine 200 mg)
Pill imprint 44 226 has been identified as Stay awake tabs Caffeine 200 mg.
Caffeine is used in the treatment of hypersomnia; apnea of prematurity; asthma and belongs to the drug class CNS stimulants. Caffeine Citrate Injection: Risk cannot be ruled out during pregnancy. Excluding Caffeine Citrate Injection: FDA has not classified the drug for risk during pregnancy. Caffeine Caffeine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 44 226
- Caffeine 200 mg
- Rx and/or OTC
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out - Caffeine Citrate Injection
N - Not classified - excluding Caffeine Citrate Injection
- CSA Schedule:
- Not a controlled drug
- Major Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
calcium phosphate dibasic anhydrous
D&C Yellow No. 10
FD&C Yellow No. 6
More about caffeine
- Caffeine Citrate
- Caffeine solution
- Caffeine (Advanced Reading)
- Caffeine citrate Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.